EN DE
STOCK COMPARISON

Procter & Gamble Health vs Sun Pharmaceutical Industries: Fair Value & Quality

Both stocks run through our valuation models. Here is how Procter & Gamble Health (PGHL) and Sun Pharmaceutical Industries (SUNPHARMA) compare, as of Aug 23, 2026.

As of Aug 23, 2026, Fair Value Calculator sees Sun Pharmaceutical Industries as the less overvalued of the two: Procter & Gamble Health trades at ₹5,829 versus a fair value of ₹3,533 (-39%), while Sun Pharmaceutical Industries trades at ₹1,902 versus ₹1,781 (-6%).
Procter & Gamble Health
PGHL.NSE · INR · Health Care
-39%
upside to fair value
overvalued
Price₹5,829
Fair Value₹3,533
Quality93/100
Sun Pharmaceutical Industries
SUNPHARMA.NSE · INR · Health Care
-6%
upside to fair value
fairly valued
Price₹1,902
Fair Value₹1,781
Quality65/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Procter & Gamble HealthSun Pharmaceutical Industries
Valuation
29.6×P/E (TTM)40.5×
7.55×P/S (TTM)7.93×
20.26×P/B5.55×
22.9×EV/EBITDA27.7×
PEG1.04×
2.7%Dividend yield0.8%
₹155Dividend per share₹16.00
Profitability
23%Net margin20%
35%Operating margin19%
62%Return on equity15%
33%Return on assets8%
Growth
19%Revenue growth (YoY)13%
4.6%Avg. growth/yr (3Y)10.0%
4.0%Avg. growth/yr (5Y)11.8%
Balance & size
0.01×Debt / equity
$1BMarket cap$48B
healthyGrowth qualityhealthy

Procter & Gamble Health leads: 9 to 3 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Procter & Gamble Healthof which business quality 87 · market factors 59 Sun Pharmaceutical Industriesof which business quality 65 · market factors 70
ProfitabilityMargins and returns on capital today
99
58
Quality GrowthAre margins and returns improving?
72
41
CashflowEarnings quality: real cash, not paper profit
78
62
Fin. StrengthBalance sheet, leverage, solvency risk
94
87
InvestmentDisciplined investing over empire-building
100
51
Low VolatilityCalm price path (market factor)
91
96
MomentumPrice trend over the last 3–12 months (market factor)
50
54
52W MomentumDistance to the 52-week high (market factor)
40
69
Net IssuanceBuybacks instead of dilution
82
81

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Procter & Gamble Health

DCF Models₹3,878
Earnings-Based₹1,836
Dividend Discount₹3,577
Multiples₹3,465
Asset-Based₹212
Growth DCF₹3,352
Economic Profit₹1,832
Growth Earnings₹3,937

26 of 26 models see the stock below the current price.

Sun Pharmaceutical Industries

DCF Models₹1,247
Earnings-Based₹689
Dividend Discount₹313
Multiples₹911
Asset-Based₹233
Growth DCF₹1,058
Economic Profit₹588
Growth Earnings₹1,039

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Procter & Gamble Health
Bear ₹2,285Fair Value ₹3,533Bull ₹4,920
₹5,829 = current price (white tick)
Sun Pharmaceutical Industries
Bear ₹1,091Fair Value ₹1,781Bull ₹2,213
₹1,902 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Procter & Gamble Health · Health Care

Quality score93 · Top 25%
Fair value upside-39% · below median

Sun Pharmaceutical Industries · Health Care

Quality score65 · Top 25%
Fair value upside-6% · above median

Bottom line

As of Aug 23, 2026, Fair Value Calculator sees Sun Pharmaceutical Industries as the less overvalued of the two: Procter & Gamble Health trades at ₹5,829 versus a fair value of ₹3,533 (-39%), while Sun Pharmaceutical Industries trades at ₹1,902 versus ₹1,781 (-6%).

Procter & Gamble Health has the higher quality score (93/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.